Carmustine in Treating Patients With Recurrent Malignant Glioma

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 1996

Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG

carmustine

PROCEDURE

conventional surgery

Trial Locations (9)

30322

Emory University Hospital - Atlanta, Atlanta

48202

Henry Ford Hospital, Detroit

35294-3295

University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham

33612-9497

H. Lee Moffitt Cancer Center and Research Institute, Tampa

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

02114

Massachusetts General Hospital Cancer Center, Boston

27157-1082

Comprehensive Cancer Center at Wake Forest University, Winston-Salem

19104-4283

University of Pennsylvania Cancer Center, Philadelphia

78284-7811

University of Texas Health Science Center at San Antonio, San Antonio

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00004028 - Carmustine in Treating Patients With Recurrent Malignant Glioma | Biotech Hunter | Biotech Hunter